Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
fda
life sciences
medicare
2
×
national
national blog main
national top stories
new york blog main
2
×
new york top stories
san francisco blog main
san francisco top stories
acute myeloid leukemia
alex azar
alliance for aging research
alx oncology
amgen
autoimmune diseases
berkeley lights
biogen
biotech
biotech ipos
biotechnology innovation organization
boulder/denver blog main
boulder/denver top stories
cancer drugs
cancer immunotherapy
cd47
chronic kidney disease
clinical trials
deals
deerfield healthcare technology acquisitions
deerfield management company
detroit blog main
detroit top stories
drug pricing
duane schulthess
eli lilly
erica whittaker
europe blog main
What
industry
2
×
administration
angry
anti
arrival
benefited
biotech
companies
days
despite
drug
fear
hasn’t
ipo
ipos
life
losing
market
momentum
new
pharma
plans
presidential
price
raised
research
rhetoric
rx
scalps
science
slowed
split
street
summer’s
thanks
trump
tweets
wall
week
welcomed
Language
unset
Current search:
industry
×
medicare
×
" new york blog main "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
